Becton Dickinson & Co Stock Price, News & Analysis

BD (Becton, Dickinson and Company) has announced its participation in several virtual investor healthcare conferences in May 2021. Key events include the Bank of America Securities 2021 Virtual Healthcare Conference on May 12 at 2:45 PM ET and the UBS Global Healthcare Virtual Conference on May 24 at 2:00 PM ET. Presentations will be available via live webcasts on the BD corporate website, with replays accessible for at least seven days post-event. BD, a global leader in medical technology, focuses on advancing healthcare through innovation.

BD (Becton, Dickinson and Company) has initiated enrollment in the post-market CONNECT-AV study for the WavelinQ™ EndoAVF System, aimed at evaluating its effectiveness in hemodialysis access. This prospective study will track 280 patients over 24 months, measuring primary endpoints such as successful cannulation rates and device safety. The global hemodialysis patient population relies heavily on AV fistulas, making this research critical. BD's innovative approach provides a minimally invasive option compared to traditional surgical methods, enhancing patient care.

BD (Becton, Dickinson and Company) has appointed Elizabeth McCombs as executive vice president and chief technology officer, effective April 26, 2021. McCombs, with over 20 years of experience in medical device innovation, previously led R&D for BD's Medical Segment. Her role will focus on driving the company's innovation strategy and managing R&D efforts. Additionally, BD has established a new Scientific Advisory Board to enhance its innovation pipeline, with John DeFord as co-chair following his retirement on May 28, 2021.

The Board of Directors of BD (Becton, Dickinson and Company) has announced a quarterly dividend of $0.83 per common share, payable on June 30, 2021 to shareholders on record as of June 9, 2021. This indicates an annual dividend rate of $3.32 per share, reflecting the company's commitment to returning value to its investors.

On April 27, 2021, CerTest Biotec and BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit can now detect COVID-19 using saliva specimens on the BD MAX™ Molecular Diagnostic System. This addition enhances testing flexibility, allowing for nasopharyngeal, oropharyngeal, and saliva sample collection. The kit is CE marked and capable of detecting all known SARS-CoV-2 variants, essential for managing the ongoing pandemic in Europe.

BD (Becton, Dickinson and Company) has submitted a 510(k) premarket notification to the U.S. FDA for its BD Alaris™ System, a widely used infusion pump in U.S. hospitals. The submission aims to update regulatory clearance, implement new features, and address existing recall issues. The new software version will enhance clinical, operational, and cybersecurity aspects. BD emphasizes this submission as a pivotal step in their commitment to healthcare improvement. However, the FDA review process includes risks and there is no guarantee of clearance or specific timing.

BD (Becton, Dickinson and Company) has partnered with USA Track & Field (USATF) to implement rapid COVID-19 testing for athletes at the Journey to Gold events. Utilizing the BD Veritor™ Plus system, tests will be administered to ensure athlete safety as they prepare for the U.S. Olympic Trials. The testing program includes administering tests every two days, exceeding U.S. Olympic Committee guidelines. To date, 410 tests have been conducted with two positive results. This initiative aligns with BD's commitment to supporting safe return to competition and community health.

BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator due to a manufacturing defect that can lead to broken glass and solution release. The recall affects products distributed in the United States and Puerto Rico. While no severe injuries have been reported, potential risks include superficial to deep lacerations and possible infection. BD has received 56 complaints, with one incident of laceration. The company is notifying affected customers and providing disposal instructions.